Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
64.78
-0.55 (-0.84%)
At close: May 3, 2024, 4:00 PM
64.79
+0.01 (0.02%)
After-hours: May 3, 2024, 7:59 PM EDT
Gilead Sciences Employees
Gilead Sciences had 18,000 employees on December 31, 2023. The number of employees increased by 1,000 or 5.88% compared to the previous year.
Employees
18,000
Change (1Y)
1,000
Growth (1Y)
5.88%
Revenue / Employee
$1,506,444
Profits / Employee
$314,722
Market Cap
80.78B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
Dec 31, 2021 | 14,400 | 800 | 5.88% |
Dec 31, 2020 | 13,600 | 2,600 | 23.64% |
Jan 31, 2019 | 11,000 | 1,000 | 10.00% |
Jan 31, 2018 | 10,000 | 1,000 | 11.11% |
Jan 31, 2017 | 9,000 | 1,000 | 12.50% |
Jan 31, 2016 | 8,000 | 1,000 | 14.29% |
Jan 31, 2015 | 7,000 | 900 | 14.75% |
Jan 31, 2014 | 6,100 | 1,100 | 22.00% |
Jan 31, 2013 | 5,000 | 500 | 11.11% |
Jan 31, 2012 | 4,500 | 500 | 12.50% |
Jan 31, 2011 | 4,000 | 148 | 3.84% |
Jan 31, 2010 | 3,852 | 411 | 11.94% |
Jan 31, 2009 | 3,441 | 462 | 15.51% |
Jan 31, 2008 | 2,979 | 464 | 18.45% |
Jan 31, 2007 | 2,515 | 615 | 32.37% |
Jan 31, 2006 | 1,900 | 246 | 14.87% |
Feb 28, 2005 | 1,654 | 229 | 16.07% |
Feb 27, 2004 | 1,425 | 175 | 14.00% |
Feb 28, 2003 | 1,250 | 250 | 25.00% |
Feb 28, 2002 | 1,000 | 150 | 17.65% |
Feb 28, 2001 | 850 | 90 | 11.84% |
Dec 31, 1999 | 760 | 467 | 159.39% |
Dec 31, 1998 | 293 | 4 | 1.38% |
Dec 31, 1997 | 289 | 41 | 16.53% |
Dec 31, 1996 | 248 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 310,000 |
CVS Health | 300,000 |
Becton, Dickinson and Company | 73,000 |
Cigna | 72,500 |
GSK | 70,212 |
McKesson | 51,000 |
Bristol-Myers Squibb Company | 34,100 |
Edwards Lifesciences | 19,800 |
GILD News
- 3 days ago - Gilead Sciences to Present at Upcoming Investor Conferences - Business Wire
- 8 days ago - FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV - Business Wire
- 8 days ago - Gilead Beats Earnings Expectations After Rocky Quarter - Barrons
- 8 days ago - Gilead's quarterly loss is narrower than expected - Market Watch
- 8 days ago - Gilead posts quarterly loss, revenue rises 5% - Reuters
- 8 days ago - Gilead Sciences Announces First Quarter 2024 Financial Results - Business Wire
- 23 days ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga
- 25 days ago - Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024 - Business Wire